Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
16 MAY 2025 NEWS

Caffeine metabolites as biomarkers for diabetic eye damage

14 MAY 2025 NEWS

Unlocking hidden biomarkers: new workflow detects trace glycoproteins in blood plasma

12 MAY 2025 JOURNAL ARTICLES

Enhancing clinical research with pharmacogenomics: a practical perspective

9 MAY 2025 NEWS

GenAI to be rolled out across all FDA centers

9 MAY 2025 CONFERENCE REPORTS

1M PMI: The launch event of the most ambitious study of human health in history?

8 MAY 2025 EXPERT OPINION

An overview of plasma protein binding

1 / 6

Sign up for our Bioanalysis Zone weekly news round-up

30 APR 2025 NEWS / ARTICLE

Reid Mentorship Program Announcement

25 APR 2025 EXPERT OPINION / ARTICLE

Implementing AI-driven digital transformation in bioanalysis

23 APR 2025 INTERVIEWS / ARTICLE

RadioADME studies of oligonucleotides: an interview with Deborah Watson


Journal Content

20 FEB 2025 Research Article / Bioanalysis

Development and qualification of an LC-MS/MS method for quantification of MUC5AC and...

7 FEB 2025 Short Communication / Bioanalysis

Improved real-world UHPLC-MS/MS iohexol analysis; thawed samples, improved calibration curve, and additional...

18 DEC 2024 Research Article / Bioanalysis

Development of a validated novel bead extraction method for the detection of...

4 DEC 2024 Methodology / Bioanalysis

A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkers

15 OCT 2024 Methodology / Bioanalysis

An immunoassay for the quantification of phosphorylated α-synuclein at serine 129 in...

8 OCT 2024 Research Article / Bioanalysis

Assessment of mirvetuximab soravtansine immunogenicity in patients with folate receptor alpha-positive ovarian...

12 SEP 2024 Research Article / Bioanalysis

Interference from anti-drug antibodies on the quantification of insulin: a comparison of...

5 SEP 2024 Bioanalytical Challenge / Bioanalysis

Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device

4 SEP 2024 Bioanalytical Challenge / Bioanalysis

Assessing prognosis by quantifying FcγRIIa on fixed platelets

Latest Articles Current Issue List of Issues

Featured

ANTIBODIES | ADCS / PODCAST

Unveiling bioanalytical datasets for the successful development of ADCs

INTERVIEWS / PODCAST

Bridging science and safety: exploring toxicology studies and regulatory requirements

GenAI
INTERVIEWS / PODCAST

The use of GenAI in bioanalysis: an interview with Priyata Kalra

quantitation
INTERVIEWS / PODCAST

The need for HRMS for quantitation of ADCs vs. QqQ: an interview with Megan Cooley

ADC bioanalytics
SPOTLIGHT

ADC bioanalytics

SPOTLIGHT

Bioanalytical support for AAV therapies

CGTs
ADVANCED THERAPIES / PODCAST

The new frontier: assessing efficacy and safety of CGTs using biomarkers

INTERVIEWS / PODCAST

Challenges and solutions in monitoring assay performance for vaccine development: an interview with Atul Chaudhari

IN THE ZONE

In the Zone: the importance of monitoring assay performance and maintenance

INTERVIEWS / PODCAST

ADA detection and characterization for immunogenicity testing: insights from ICON's Lindsay Denhoff

Must Watch

CELL AND GENE THERAPIES / WEBINAR

Molecular bioanalysis considerations along the drug development journey

21 MAR 2025 PANEL DISCUSSIONS / WEBINAR

Panel discussion: ADC bioanalytics

18 FEB 2025 ANTIBODIES | ADCS / WEBINAR

Beyond traditional immunoassays: LC–MS for antibody isotyping and quantitation

10 FEB 2025 ANTIBODIES | ADCS / WEBINAR

Strategies for ADC bioanalysis

AWARENESS / WEBINAR

Breaking the bias in women's health: exploring sex differences in drug metabolism and toxicology

physiochemical
INTERVIEWS / VIDEO

Harmonizing physiochemical profiling for therapeutic oligonucleotides: an interview with Kohsaku Kawakami

oligonucleotide assessment strategies
ADVANCED THERAPIES / WEBINAR

Panel discussion: bioanalytical considerations for oligonucleotide assessment strategies

ANTIBODIES | ADCS / WEBINAR

Accelerating PK and ADA bioanalytical assay development

DRUG DEVELOPMENT / VIDEO

Piet van der Graaf on AI and AI-assisted approaches in drug discovery & development

INTERVIEWS / VIDEO

Working with a CRO: Sara Underwood on bioanalytical and PK projects

What's Trending?

NEWS / ARTICLE

FDA rewrites drug development rules: animal testing out, human biology in

MS (LC–MS/MS, HRMS, IMS) / ARTICLE

Analysis of semaglutide from human plasma by LC-MS/MS

INTERVIEWS / ARTICLE

RadioADME studies of oligonucleotides: an interview with Deborah Watson

NEWS / ARTICLE

GenAI to be rolled out across all FDA centers

EXPERT OPINION / ARTICLE

Implementing AI-driven digital transformation in bioanalysis

EXPERT OPINION / ARTICLE

An overview of plasma protein binding

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone